Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents - PubMed (original) (raw)
. 1999 May;105(5):2951-7.
doi: 10.1121/1.426908.
Affiliations
- PMID: 10335644
- DOI: 10.1121/1.426908
Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents
M Ward et al. J Acoust Soc Am. 1999 May.
Abstract
The enhancement of ultrasound-induced cell destruction, lysis, and sonoporation in low cell concentration suspensions (2 x 10(5)/mL) by the presence of contrast agents (gas bubble to cell ratio = 230) was demonstrated using cervical cancer cells (HeLa S3) suspensions containing micron-size denatured albumin microspheres filled with air (Albunex) or octafluoropropane (Optison). The suspensions were insonificated by 2-MHz continuous or tone burst ultrasound in near field. The spatial peak-pressure amplitude was 0.2 MPa. The enhancement of cell destruction due to Optison was shown to be much higher than that due to Albunex for similar bubble concentration and ultrasound conditions. For tone burst exposures, significant lysis and sonoporation only occurred in the presence of a contrast agent. The majority of the bioeffects observed occurred in the first 5 min of exposure. The relationship between the enhancement of bioeffects and duty cycle of tone burst ultrasound appears to indicate that both stable gas spheres of contrast agents and cavitation nuclei created by the disruption of the gas spheres play a significant role in causing the bioeffects.
Similar articles
- Experimental study of the effects of Optison concentration on sonoporation in vitro.
Ward M, Wu J, Chiu JF. Ward M, et al. Ultrasound Med Biol. 2000 Sep;26(7):1169-75. doi: 10.1016/s0301-5629(00)00260-x. Ultrasound Med Biol. 2000. PMID: 11053752 - Sonoporation of cultured cells in the rotating tube exposure system.
Miller DL, Bao S, Morris JE. Miller DL, et al. Ultrasound Med Biol. 1999 Jan;25(1):143-9. doi: 10.1016/s0301-5629(98)00137-9. Ultrasound Med Biol. 1999. PMID: 10048811 - Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents.
Miller DL, Gies RA. Miller DL, et al. Ultrasound Med Biol. 1998 Feb;24(2):285-92. doi: 10.1016/s0301-5629(97)00267-6. Ultrasound Med Biol. 1998. PMID: 9550187 - Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation.
Miller DL. Miller DL. Prog Biophys Mol Biol. 2007 Jan-Apr;93(1-3):314-30. doi: 10.1016/j.pbiomolbio.2006.07.027. Epub 2006 Aug 22. Prog Biophys Mol Biol. 2007. PMID: 16989895 Review. - Bioeffects considerations for diagnostic ultrasound contrast agents.
Miller DL, Averkiou MA, Brayman AA, Everbach EC, Holland CK, Wible JH Jr, Wu J. Miller DL, et al. J Ultrasound Med. 2008 Apr;27(4):611-32; quiz 633-6. doi: 10.7863/jum.2008.27.4.611. J Ultrasound Med. 2008. PMID: 18359911 Review.
Cited by
- Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors.
Tu J, Yu ACH. Tu J, et al. BME Front. 2022 Jan 29;2022:9807347. doi: 10.34133/2022/9807347. eCollection 2022. BME Front. 2022. PMID: 37850169 Free PMC article. Review. - The role of acoustofluidics and microbubble dynamics for therapeutic applications and drug delivery.
Kaykanat SI, Uguz AK. Kaykanat SI, et al. Biomicrofluidics. 2023 Apr 10;17(2):021502. doi: 10.1063/5.0130769. eCollection 2023 Mar. Biomicrofluidics. 2023. PMID: 37153864 Free PMC article. Review. - SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
Kotopoulis S, Popa M, Mayoral Safont M, Murvold E, Haugse R, Langer A, Dimcevski G, Lam C, Bjånes T, Gilja OH, Cormack EM. Kotopoulis S, et al. Pharmaceutics. 2022 Jan 1;14(1):98. doi: 10.3390/pharmaceutics14010098. Pharmaceutics. 2022. PMID: 35056994 Free PMC article. - Applications of Ultrasound-Mediated Drug Delivery and Gene Therapy.
Sitta J, Howard CM. Sitta J, et al. Int J Mol Sci. 2021 Oct 25;22(21):11491. doi: 10.3390/ijms222111491. Int J Mol Sci. 2021. PMID: 34768922 Free PMC article. Review. - Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.
Choromańska A, Chwiłkowska A, Kulbacka J, Baczyńska D, Rembiałkowska N, Szewczyk A, Michel O, Gajewska-Naryniecka A, Przystupski D, Saczko J. Choromańska A, et al. Molecules. 2021 Mar 25;26(7):1850. doi: 10.3390/molecules26071850. Molecules. 2021. PMID: 33806009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources